Ureteral stents: past, present and future

For three decades, intraureteral tubular devices have been used to maintain ureteral patency. The contribution of stents to modern urology is invaluable, since these devices are closely associated with everyday urologic practice. Polymeric stents represent the most commonly used type of stent, while metal stents are indicated in selected cases. Nevertheless, several problems have been observed related to the use of stents. Constant development of new biomaterials, together with improvements in design, attempts to overcome any stent-related adverse events.

[1]  W. Pauer,et al.  Metallic Wallstents: a new therapy for extrinsic ureteral obstruction. , 1992, The Journal of urology.

[2]  M. Leon,et al.  Angiographic results of the first human experience with the Biolimus A9 drug-eluting stent for de novo coronary lesions. , 2006, The American journal of cardiology.

[3]  J. Richie,et al.  The effects of various indwelling ureteral catheter materials on the normal canine ureter. , 1988, The Journal of urology.

[4]  P. Serruys,et al.  Accelerated vascular repair following percutaneous coronary intervention by capture of endothelial progenitor cells promotes regression of neointimal growth at long term follow-up: final results of the Healing II trial using an endothelial progenitor cell capturing stent (Genous R stent). , 2007, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[5]  J. Cartledge,et al.  Initial Experience with the Resonance Metallic Stent for Antegrade Ureteric Stenting , 2007, CardioVascular and Interventional Radiology.

[6]  Bernard Chevalier,et al.  Comparison of in vivo acute stent recoil between the bioabsorbable everolimus‐eluting coronary stent and the everolimus‐eluting cobalt chromium coronary stent: Insights from the ABSORB and SPIRIT trials , 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[7]  Y. Nakayama,et al.  Development of in vivo tissue-engineered autologous tissue-covered stents (biocovered stents) , 2007, Journal of Artificial Organs.

[8]  P. Serruys,et al.  Circulating endothelial progenitor cells predict angiographic and intravascular ultrasound outcome following percutaneous coronary interventions in the HEALING-II trial: evaluation of an endothelial progenitor cell capturing stent. , 2007, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[9]  B. Laven,et al.  Percutaneous placement of permanent metal stents for treatment of ureteroenteric anastomotic strictures. , 2004, Journal of endourology.

[10]  G. Nikiforidis,et al.  Application of Paclitaxel-Eluting Metal Mesh Stents within the Pig Ureter: An Experimental Study , 2007 .

[11]  H. Eggebrecht,et al.  Absorbable metal stent in human coronary arteries: imaging with intravascular ultrasound , 2006, Heart.

[12]  F. Keeley,et al.  Characterization of urinary symptoms in patients with ureteral stents. , 2002, Urology.

[13]  P. Serruys,et al.  Biodegradable drug eluting stents: invasive and non-invasive imaging. , 2006, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[14]  Kulkarni,et al.  A new thermo‐expandable shape‐memory nickel‐titanium alloy stent for the management of ureteric strictures , 1999, BJU international.

[15]  J. Thornhill,et al.  'Firm' versus 'soft' double pigtail ureteric stents: a randomised blind comparative trial. , 1995, European Urology.

[16]  Bodo E. Knudsen,et al.  Urinary tract biomaterials. , 2004, The Journal of urology.

[17]  J. Chin,et al.  Retrieval of proximally migrated ureteral stents. , 1992, The Journal of urology.

[18]  A. Rané,et al.  Have stent-related symptoms anything to do with placement technique? , 2001, Journal of endourology.

[19]  P. Tenke,et al.  Bacterial biofilm formation on urologic devices and heparin coating as preventive strategy. , 2004, International journal of antimicrobial agents.

[20]  W. Mali,et al.  Metallic self-expandible stenting of a ureteroileal stricture. , 1990, AJR. American journal of roentgenology.

[21]  J. Cummings,et al.  Endoscopic management of ureteral complications following renal transplantation. , 2006, Transplantation proceedings.

[22]  R. Virmani,et al.  Particle debris from a nanoporous stent coating obscures potential antiproliferative effects of tacrolimus‐eluting stents in a porcine model of restenosis , 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[23]  S. Millward,et al.  Ureteral response to the placement of metallic stents: an animal model. , 1994, The Journal of urology.

[24]  T. Tammela,et al.  Biocompatibility, encrustation and biodegradation of ofloxacine and silver nitrate coated poly-L-lactic acid stents in rabbit urethra , 2002, Urological Research.

[25]  G. Nikiforidis,et al.  Ureteropelvic junction obstruction: an innovative approach combining metallic stenting and virtual endoscopy. , 2002, The Journal of urology.

[26]  G. Nikiforidis,et al.  Application of self-expandable metal stents for ureteroileal anastomotic strictures: long-term results. , 2007, The Journal of urology.

[27]  R. Thomas Indwelling ureteral stents: impact of material and shape on patient comfort. , 1993, Journal of endourology.

[28]  F. Marshall,et al.  Percutaneous management of benign ureteral strictures and fistulas. , 1987, The Journal of urology.

[29]  S. Gorman,et al.  Biofilm and biofilm-related encrustation of urinary tract devices. , 1999, Methods in Enzymology.

[30]  P. Serruys,et al.  A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. , 2007, The New England journal of medicine.

[31]  C. Fry,et al.  Catheter associated urinary tract infection and encrustation. , 2001, International journal of antimicrobial agents.

[32]  Manoj Monga,et al.  Wire-based ureteral stents: impact on tensile strength and compression. , 2007, Urology.

[33]  T. Tammela,et al.  Tissue biocompatibility of a new caprolactone-coated self-reinforced self-expandable poly-L-lactic acid bioabsorbable urethral stent. , 1999, Journal of endourology.

[34]  M. Urban,et al.  Treatment of benign ureterointestinal anastomotic strictures with permanent ureteral Wallstent after Camey and Wallace urinary diversion: long-term follow-up. , 2001, Journal of endourology.

[35]  S. Gorman,et al.  Evaluation of a poly(vinyl pyrollidone)-coated biomaterial for urological use. , 2002, Biomaterials.

[36]  P. Serruys,et al.  Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry. , 2005, Journal of the American College of Cardiology.

[37]  C. Riedl,et al.  Heparin coating reduces encrustation of ureteral stents: a preliminary report. , 2002, International journal of antimicrobial agents.

[38]  C. Kalogeropoulou,et al.  Externally coated ureteral metallic stents: an unfavorable clinical experience. , 2002, European urology.

[39]  G. Bellman,et al.  Ureteral stents: impact of diameter and composition on patient symptoms. , 1997, Journal of endourology.

[40]  D. Stickler,et al.  Strategies for the control of catheter encrustation. , 2002, International journal of antimicrobial agents.

[41]  P. Fitzgerald,et al.  Comparison of vascular response to zotarolimus-eluting stent versus sirolimus-eluting stent: intravascular ultrasound results from ENDEAVOR III. , 2008, American heart journal.

[42]  Frank Litvack,et al.  The effect of variable dose and release kinetics on neointimal hyperplasia using a novel paclitaxel-eluting stent platform: the Paclitaxel In-Stent Controlled Elution Study (PISCES). , 2005, Journal of the American College of Cardiology.

[43]  Laura Wilkes Evans,et al.  XTENT(R) Custom NX drug eluting stent systems. , 2007, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[44]  C. Young,et al.  Retrograde stenting for obstruction of the renal transplant ureter. , 2005, Urology.

[45]  P. Teillac,et al.  Experimental study of Wallstent self-expandable metal stent in ureteral implantation. , 1995, Journal of endourology.

[46]  R. Clayman,et al.  In-vivo evaluation of flow characteristics of novel metal ureteral stent. , 2007, Journal of endourology.

[47]  P. Serruys,et al.  MAHOROBA: Tacrolimus eluting coronary stent. , 2007, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[48]  J. Kepros,et al.  Bilateral partial ureteropelvic junction disruption after blunt trauma treated with indwelling ureteral stents. , 2007, Urology.

[49]  K. Hauptmann,et al.  Six-month results of a randomized study to evaluate safety and efficacy of a Biolimus A9 eluting stent with a biodegradable polymer coating. , 2005, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[50]  P. Klarskov,et al.  Experience with Memokath 051 ureteral stent , 2005, Scandinavian journal of urology and nephrology.

[51]  R. Clayman,et al.  Initial experience with full-length metal stent to relieve malignant ureteral obstruction. , 2006, Journal of endourology.

[52]  R. Leveillee,et al.  Endoscopic management of ureterointestinal strictures after radical cystectomy. , 2005, Journal of endourology.

[53]  J. Stolzenburg,et al.  Ureteral obstruction: is the full metallic double-pigtail stent the way to go? , 2010, European urology.

[54]  James D Watterson,et al.  Use of a temporary ureteral drainage stent after uncomplicated ureteroscopy: results from a phase II clinical trial. , 2003, The Journal of urology.

[55]  J. Stolzenburg,et al.  Ureteric response to abdominal radiotherapy and metallic double‐pigtail ureteric stents: a pig model , 2009, BJU international.

[56]  Benjamin R. Lee,et al.  Novel dual-lumen ureteral stents provide better ureteral flow than single ureteral stent in ex vivo porcine kidney model of extrinsic ureteral obstruction. , 2006, Urology.

[57]  Chi‐Hang Lee,et al.  Sirolimus-eluting, bioabsorbable polymer-coated constant stent (Cura) in acute ST-elevation myocardial infarction: a clinical and angiographic study (CURAMI Registry). , 2007, The Journal of invasive cardiology.

[58]  P. Serruys,et al.  One-year clinical outcome of various doses and pharmacokinetic release formulations of paclitaxel eluted from an erodable polymer - Insight in the Paclitaxel In-Stent Controlled Elution Study (PISCES). , 2005, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[59]  T. Tammela,et al.  A bioabsorbable self-expandable, self-reinforced poly-L-lactic acid urethral stent for recurrent urethral strictures: long-term results. , 2002, Journal of endourology.

[60]  W. Pauer,et al.  Wallstents for the treatment of extrinsic malignant ureteral obstruction: midterm results. , 1996, Radiology.

[61]  A. El-Assmy,et al.  Is pre-shock wave lithotripsy stenting necessary for ureteral stones with moderate or severe hydronephrosis? , 2006, Journal of Urology.

[62]  R. Clayman,et al.  Evaluation of the use of a biodegradable ureteral stent after retrograde endopyelotomy in a porcine model. , 2002, The Journal of urology.

[63]  R. Clayman,et al.  Clinical effectiveness of new stent design: randomized single-blind comparison of tail and double-pigtail stents. , 2000, Journal of endourology.

[64]  M. Monga,et al.  Alfuzosin to relieve ureteral stent discomfort: a prospective, randomized, placebo controlled study. , 2009, The Journal of urology.

[65]  J. Hulbert,et al.  Intraureteral metallic self-expanding endoprosthesis (Wallstent) in the treatment of difficult ureteral strictures. , 1994, The Journal of urology.

[66]  J. Lam,et al.  Update on ureteral stents. , 2004, Urology.

[67]  P. Serruys,et al.  One-year results of a durable polymer everolimus-eluting stent in de novo coronary narrowings (The SPIRIT FIRST Trial). , 2005, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[68]  W. Roberts,et al.  Success of ureteral stents for intrinsic ureteral obstruction. , 2008, Journal of endourology.

[69]  G. Preminger,et al.  Evaluation of a dissolvable ureteral drainage stent in a Swine model. , 2002, The Journal of urology.

[70]  Jörg Hausleiter,et al.  Randomized Trial of a Nonpolymer-Based Rapamycin-Eluting Stent Versus a Polymer-Based Paclitaxel-Eluting Stent for the Reduction of Late Lumen Loss , 2006, Circulation.

[71]  Zhaohui He,et al.  Long‐term results of permanent metallic stent implantation in the treatment of benign upper urinary tract occlusion , 2007, International journal of urology : official journal of the Japanese Urological Association.

[72]  Raimund Erbel,et al.  Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial , 2007, The Lancet.

[73]  W. Pauer,et al.  Self-expanding metal stents for palliative treatment of malignant ureteral obstruction. , 1992, AJR. American journal of roentgenology.

[74]  J. Dimopoulos,et al.  Metal stents: a new treatment of malignant ureteral obstruction. , 1997, The Journal of urology.

[75]  Brett Trauthen,et al.  Six-month clinical and angiographic results of a dedicated drug-eluting stent for the treatment of coronary bifurcation narrowings. , 2007, The American journal of cardiology.

[76]  J. D. Del Pizzo,et al.  Endoscopic retrograde stenting for allograft hydronephrosis. , 1999, Journal of endourology.

[77]  Ron Waksman,et al.  Short-term effects of biocorrodible iron stents in porcine coronary arteries. , 2008, Journal of interventional cardiology.

[78]  U. Nagele,et al.  Initial clinical experience with full-length metal ureteral stents for obstructive ureteral stenosis , 2008, World Journal of Urology.

[79]  T. Tammela,et al.  A bioabsorbable self-expandable, self-reinforced poly-l-lactic acid urethral stent for recurrent urethral strictures: a preliminary report. , 1998, The Journal of urology.

[80]  E. Liatsikos,et al.  Ureteroileal anastomotic strictures: an innovative approach with metallic stents. , 1998, The Journal of urology.

[81]  G. Nabi,et al.  Outcomes of stenting after uncomplicated ureteroscopy: systematic review and meta-analysis , 2007, BMJ : British Medical Journal.

[82]  J. Costerton,et al.  Bacterial biofilms in nature and disease. , 1987, Annual review of microbiology.

[83]  P. Kallidonis,et al.  Metallic double pigtail ureteral stent usage during extracorporeal shock wave lithotripsy in the swine model: is there any effect on the ureter? , 2009, Journal of endourology.

[84]  R. Kulkarni,et al.  Nickel-titanium shape memory alloy Memokath 051 ureteral stent for managing long-term ureteral obstruction: 4-year experience. , 2001, The Journal of urology.

[85]  P. Törmälä,et al.  Bioabsorbable SR-PLGA horn stent after antegrade endopyelotomy: a case report. , 2002, Journal of endourology.

[86]  C. Choi,et al.  Tissue hyperplasia: influence of a paclitaxel-eluting covered stent--preliminary study in a canine urethral model. , 2005, Radiology.

[87]  G. Reid,et al.  Oxalate-degrading enzymes from Oxalobacter formigenes: a novel device coating to reduce urinary tract biomaterial-related encrustation. , 2003, Journal of endourology.

[88]  Marco Valgimigli,et al.  Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. , 2007, The New England journal of medicine.

[89]  K. Loughlin,et al.  The management of malignant ureteral obstruction treated with ureteral stents. , 2005, The Journal of urology.

[90]  J. Ge,et al.  Effectiveness and safety of the sirolimus‐eluting stents coated with bioabsorbable polymer coating in human coronary arteries , 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[91]  P. Hunold,et al.  Images in cardiovascular medicine. Novel magnetic resonance-compatible coronary stent: the absorbable magnesium-alloy stent. , 2005, Circulation.

[92]  G. Reid,et al.  Biomaterials used in urology: current issues of biocompatibility, infection, and encrustation. , 1998, Journal of endourology.

[93]  W. Roberts,et al.  UROLITHIASIS, ENDOUROLOGY AND LAPAROSCOPY Retrograde Ureteral Stents for Extrinsic Ureteral Obstruction: Nine Years' Experience at University of Michigan , 2008 .

[94]  G. Nikiforidis,et al.  Metal Stents in the Urinary Tract , 2007 .

[95]  N. Lawrentschuk,et al.  Ureteric stenting 25 years on: routine or risky? , 2004, ANZ journal of surgery.

[96]  B. Hekimoğlu,et al.  Urothelial hyperplasia complicating use of metal stents in malignant ureteral obstruction , 2004, European Radiology.

[97]  A. Papatsoris,et al.  Material fatigue testing of a new intraureteral wire stent (Zebrastent). , 2008, Journal of endourology.

[98]  M. Kellomäki,et al.  A new biodegradable braided self-expandable PLGA prostatic stent: an experimental study in the rabbit. , 2008, Journal of endourology.

[99]  M. Birch,et al.  A new SWL titanium stent (Zebra Stent): resistance to shockwave exposure. , 2005, Journal of endourology.

[100]  S. Gorman,et al.  Comparative assessment of ureteral stent biomaterial encrustation. , 1996, Biomaterials.

[101]  K. Karsch,et al.  The future of drug eluting stents , 2005, Heart.

[102]  J. Popma,et al.  Clinical Research Interventional Cardiology Taxus Vi 2-year Follow-up: Randomized Comparison of Polymer-based Paclitaxel-eluting with Bare Metal Stents for Treatment of Long, Complex Lesions , 2022 .

[103]  S. Antimisiaris,et al.  Liposome-coated metal stents: an in vitro evaluation of controlled-release modality in the ureter. , 2000, Journal of endourology.

[104]  B. Kang,et al.  Comparison of a New Polytetrafluoroethylene-Covered Metallic Stent to a Noncovered Stent in Canine Ureters , 2008, CardioVascular and Interventional Radiology.

[105]  P. Serruys,et al.  Two-year results of a durable polymer everolimus-eluting stent in de novo coronary artery stenosis (The SPIRIT FIRST Trial). , 2007, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[106]  C. Kalogeropoulou,et al.  Metallic Stents in Gynecologic Cancer: An Approach to Treat Extrinsic Ureteral Obstruction , 2000, European Urology.

[107]  D. Delakas,et al.  Intraureteral metallic endoprosthesis in the treatment of ureteral strictures. , 2001, European journal of radiology.

[108]  Bodo E. Knudsen,et al.  Triclosan loaded ureteral stents decrease proteus mirabilis 296 infection in a rabbit urinary tract infection model. , 2006, The Journal of urology.

[109]  T. Egglin,et al.  Treatment of ureteral obstructions with the Wallstent endoprosthesis: preliminary results. , 1995, Journal of vascular and interventional radiology : JVIR.

[110]  Daniel Yachia,et al.  Recent advances in ureteral stents , 2008, Current opinion in urology.

[111]  C. Di Mario,et al.  Direct stenting of de novo coronary stenoses with tacrolimus-eluting versus carbon-coated carbostents. The randomized JUPITER II trial. , 2006, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[112]  G. Reid,et al.  In-vitro activity of triclosan-eluting ureteral stents against common bacterial uropathogens. , 2006, Journal of endourology.

[113]  C. Fiori,et al.  Heparin coating on ureteral Double J stents prevents encrustations: an in vivo case study. , 2008, Journal of endourology.

[114]  S. Antimisiaris,et al.  Heparin incorporating liposomes as a delivery system of heparin from PET-covered metallic stents: effect on haemocompatibility. , 2006, Biomaterials.

[115]  K. Hausegger,et al.  Malignant ureteral obstruction: preliminary results of treatment with metallic self-expandable stents. , 1993, Radiology.

[116]  Douglas Landsittel,et al.  15-year experience with the management of extrinsic ureteral obstruction with indwelling ureteral stents. , 2004, The Journal of urology.

[117]  P. Serruys,et al.  Biodegradable-polymer-based, paclitaxel-eluting Infinnium stent: 9-Month clinical and angiographic follow-up results from the SIMPLE II prospective multi-centre registry study. , 2006, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[118]  D. Lifshitz,et al.  Predicting the success of retrograde stenting for managing ureteral obstruction. , 2001, The Journal of urology.

[119]  B. Song,et al.  Clinical evaluation of double-pigtail stent in patients with upper urinary tract diseases: report of 2685 cases. , 2008, Journal of endourology.